ESPAC-4: a multicenter, international, randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (gem) and capecitabine (cap), versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
Neoptolemos, J Palmer, D Ghaneh, P Valle, Juan W Cunningham, D Wadsley, J Meyer, T Anthoney, A Glimelius, B Falk, S
Neoptolemos, J
Palmer, D
Ghaneh, P
Valle, Juan W
Cunningham, D
Wadsley, J
Meyer, T
Anthoney, A
Glimelius, B
Falk, S
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
ESPAC-4: a multicenter, international, randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (gem) and capecitabine (cap), versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma. 2016, 45(10): 1529-1529 Pancreas